Big Money Sentiment increased to 1.09 in 2018 Q3. It has change of 0.04, from 2018Q2’s 1.05. The ratio is positive due to Omega Healthcare Investors, Inc. positioning: 32 sold and 106 reduced. 52 funds bought holdings and 98 increased holdings. Investors holded 139.89 million in 2018Q2 but now own 141.20 million shares or 0.93% more.
42,537 were accumulated by Private Advisor Ltd Liability Company. Barclays Plc, a United Kingdom-based fund reported 351,598 shs. Lsv Asset has invested 0.24% in Omega Healthcare Investors, Inc. (NYSE:OHI). Amica Mutual Insurance, Rhode Island-based fund reported 78,152 shs. 200 were accumulated by Wealthtrust Fairport Ltd Liability Corp. Ubs Oconnor Ltd holds 0% of its capital in Omega Healthcare Investors, Inc. (NYSE:OHI) for 19,000 shs. Howe & Rusling stated it has 475 shs. Legg Mason stated it has 1,435 shs or 2.85% of all its holdings. Stratos Wealth Prns Limited accumulated 4,014 shs. State Street Corporation accumulated 6.59M shs. Private Trust Na has 0.15% invested in Omega Healthcare Investors, Inc. (NYSE:OHI) for 22,506 shs. 811,187 were reported by Ameriprise Fincl. 142,248 are held by Arizona State Retirement Systems. Scout invested in 1.22 million shs or 0.83% of the stock. Johnson Investment Counsel holds 0.01% of its capital in Omega Healthcare Investors, Inc. (NYSE:OHI) for 12,278 shs.
Omega Healthcare Investors, Inc. registered $1.39 million net activity with 0 insider purchases and 5 insider sales since November 16, 2018. INSOFT STEVEN J sold $931,200 worth of stock or 25,000 shs.
Omega Healthcare Investors, Inc. (NYSE:OHI) Ratings Coverage
Total analysts of 4 have positions in Omega Healthcare (NYSE:OHI) as follows: 1 rated it a “Buy”, 0 with “Sell” and 3 with “Hold”. The positive are 25%. Since November 16, 2018 according to StockzIntelligence Inc Omega Healthcare has 5 analyst reports. On Thursday, February 7 the rating was downgraded by Stifel Nicolaus to “Hold”. On Friday, November 16 Bank of America upgraded the shares of OHI in report to “Neutral” rating. On Friday, November 16 the stock of Omega Healthcare Investors, Inc. (NYSE:OHI) has “Outperform” rating given by Raymond James. On Thursday, November 29 the company was upgraded by Stifel Nicolaus. Listed here are Omega Healthcare Investors, Inc. (NYSE:OHI) PTs and latest ratings.
07/02/2019 Broker: Scotia Capital Rating: Sector Perform Initiates Coverage On
07/02/2019 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Hold New Target: $39 Downgrade
29/11/2018 Broker: Stifel Nicolaus Old Rating: Hold New Rating: Buy Old Target: $34 New Target: $39 Upgrade
16/11/2018 Broker: Raymond James Old Rating: Market Perform New Rating: Outperform Upgrade
16/11/2018 Broker: Bank of America Old Rating: Underperform New Rating: Neutral Upgrade
The stock decreased 0.41% or $0.16 during the last trading session, hitting $39.18.Currently Omega Healthcare Investors, Inc. is uptrending after 37.38% change in last February 10, 2018. OHI has also 1.14 million shares volume. OHI outperformed by 37.38% the S&P500.
Omega Healthcare Investors, Inc. is a real estate investment firm.The firm is valued at $8.27 billion. The firm invests in the real estate markets of United States.27.79 is the P/E ratio. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio.
For more Omega Healthcare Investors, Inc. (NYSE:OHI) news published briefly go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “Omega Healthcare Investors: Time To Sell? – Seeking Alpha” published on November 22, 2018, “Omega Healthcare Investors: Why I’m Selling – Seeking Alpha” on April 20, 2018, “Health Insurance For Your Omega Healthcare Investors Position – Seeking Alpha” with a publish date: October 29, 2018, “Omega Healthcare Investors: Don’t Get Too Excited – Seeking Alpha” and the last “Data! Data! Data! I Can’t Make Bricks Without Clay – Seeking Alpha” with publication date: April 25, 2018.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.